Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -179,178 | -174,447 | -213,391 | -168,518 | -22,820 |
| Depreciation Amortization | 31,073 | 16,473 | 55,398 | 38,456 | 24,863 |
| Income taxes - deferred | -3,540 | -2,664 | -46,658 | -34,889 | -27,698 |
| Accounts receivable | 11,329 | 13,162 | -17,672 | -12,840 | -21,157 |
| Other Working Capital | 11,057 | 8,070 | -29,730 | -37,533 | -2,890 |
| Other Operating Activity | 142,544 | 141,896 | 238,516 | 196,543 | 31,622 |
| Operating Cash Flow | $13,285 | $2,490 | $-13,537 | $-18,781 | $-18,080 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,957 | -3,560 | -1,478 | -6,639 | -4,990 |
| Net Acquisitions | 34,897 | N/A | N/A | N/A | -50,231 |
| Purchase Of Investment | N/A | 0 | -10,042 | -1,478 | -1,478 |
| Other Investing Activity | -11,506 | -11,506 | -104,916 | -104,916 | 0 |
| Investing Cash Flow | $18,434 | $-15,066 | $-116,436 | $-113,033 | $-56,699 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,000 | 49,000 | 104,659 | 104,659 | 25,000 |
| Debt Repayment | -80,264 | -20,000 | -45,038 | -38,528 | -9,019 |
| Common Stock Issued | 223 | 84 | 5,822 | 4,739 | 4,257 |
| Other Financing Activity | -3,827 | -1,704 | -3,367 | -3,356 | -3,378 |
| Financing Cash Flow | $-34,868 | $27,380 | $62,076 | $67,514 | $16,860 |
| Exchange Rate Effect | 701 | 461 | 521 | -531 | -293 |
| Beginning Cash Position | 31,837 | 31,837 | 99,213 | 99,213 | 99,213 |
| End Cash Position | 29,389 | 47,102 | 31,837 | 34,382 | 41,001 |
| Net Cash Flow | $-2,448 | $15,265 | $-67,376 | $-64,831 | $-58,212 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,285 | 2,490 | -13,537 | -18,781 | -18,080 |
| Capital Expenditure | -4,957 | -3,560 | -1,478 | -6,639 | -4,990 |
| Free Cash Flow | 8,328 | -1,070 | -15,015 | -25,420 | -23,070 |